Dental piezoelectric ultrasonic unit market was valued at US$ 230.12 million in 2024 and is projected to hit the market valuation of US$ 363.78 million by 2033 at a CAGR of 5.16% during the forecast period 2025–2033.
Cell penetrating peptide market was valued at US$ 2.16 billion in 2024 and is projected to hit the market valuation of US$ 8.12 billion by 2033 at a CAGR of 15.85 % during the forecast period 2025–2033.
The global liver fibrosis treatment market is projected to grow significantly, with revenues rising from USD 17.51 billion in 2024 to USD 51.16 billion by 2033, marking a robust compound annual growth rate (CAGR) of 10.8% throughout the forecast period 2025-233.
Interventional cardiology devices market was valued at US$ 16.89 billion in 2024 and is projected to hit the market valuation of US$ 30.23 billion by 2033 at a CAGR of 7.55% during the forecast period 2025–2033.
Europe medical devices market was valued at US$ 193.9 billion in 2024 and is projected to hit the valuation of US$ 305.01 billion by 2033 at a CAGR of 5.0% during the forecast period 2025-2033.
The U.S. medical devices market was valued at US$ 184.5 billion in 2024 and is projected to hit the valuation of US$ 311.50 billion by 2033 at a CAGR of 5.8% during the forecast period 2025-2033.
Veterinary lasers market was valued at US$ 310.12 million in 2024 and is projected to hit the market valuation of US$ 727.36 million by 2033 at a CAGR of 9.1% during the forecast period 2025–2033.
Bronchial biopsy devices market was valued at US$ 681.2 million in 2024 and is projected to hit the market valuation of US$ 1,350.4 million by 2033 at a CAGR of 7.9% during the forecast period 2025–2033.